IL1B and familial Mediterranean fever: In FMF patients, colchicine treatment led to a marked reduction in cytokine release, with IL-1β levels decreasing from a median of 2285 pg/ml to 66.0 pg/ml (Fig. 4a) and IL-18 from 1188 pg/ml to 1.0 pg/ml (Fig. 4b).